These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37511206)

  • 1. Computational Prediction of the Interaction of Ivermectin with Fibrinogen.
    Vottero P; Tavernini S; Santin AD; Scheim DE; Tuszynski JA; Aminpour M
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19.
    Grobbelaar LM; Venter C; Vlok M; Ngoepe M; Laubscher GJ; Lourens PJ; Steenkamp J; Kell DB; Pretorius E
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34328172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An
    Azam F; Taban IM; Eid EEM; Iqbal M; Alam O; Khan S; Mahmood D; Anwar MJ; Khalilullah H; Khan MU
    J Biomol Struct Dyn; 2022 Apr; 40(6):2851-2864. PubMed ID: 33131430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding behavior of receptor binding domain of the SARS-CoV-2 virus and ivermectin.
    Gossen KR; Zhang M; Nikolov ZL; Fernando SD; King MD
    Sci Rep; 2024 Feb; 14(1):2743. PubMed ID: 38302638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications.
    Kell DB; Laubscher GJ; Pretorius E
    Biochem J; 2022 Feb; 479(4):537-559. PubMed ID: 35195253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid.
    Moiseiwitsch N; Zwennes N; Szlam F; Sniecinski R; Brown A
    J Thromb Haemost; 2022 Dec; 20(12):2909-2920. PubMed ID: 36111490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational modeling of hypercoagulability in COVID-19.
    Zhu G; Modepalli S; Anand M; Li H
    Comput Methods Biomech Biomed Engin; 2023 Feb; 26(3):338-349. PubMed ID: 36154346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system.
    Kruger A; Vlok M; Turner S; Venter C; Laubscher GJ; Kell DB; Pretorius E
    Cardiovasc Diabetol; 2022 Sep; 21(1):190. PubMed ID: 36131342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy.
    Ryu JK; Sozmen EG; Dixit K; Montano M; Matsui Y; Liu Y; Helmy E; Deerinck TJ; Yan Z; Schuck R; Acevedo RM; Spencer CM; Thomas R; Pico AR; Zamvil SS; Lynch KL; Ellisman MH; Greene WC; Akassoglou K
    bioRxiv; 2021 Oct; ():. PubMed ID: 34671772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication.
    Low ZY; Yip AJW; Lal SK
    Biochim Biophys Acta Mol Basis Dis; 2022 Feb; 1868(2):166294. PubMed ID: 34687900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Analysis of SARS-CoV-2 Spike Protein and Ivermectin Interaction.
    García-Aguilar A; Campi-Caballero R; Visoso-Carvajal G; García-Sánchez JR; Correa-Basurto J; García-Machorro J; Espinosa-Raya J
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic insights into the inhibitory activity of FDA approved ivermectin against SARS-CoV-2: old drug with new implications.
    Qureshi U; Mir S; Naz S; Nur-E-Alam M; Ahmed S; Ul-Haq Z
    J Biomol Struct Dyn; 2022 Oct; 40(17):8100-8111. PubMed ID: 33950784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19.
    Kangro K; Wolberg AS; Flick MJ
    Curr Drug Targets; 2022; 23(17):1593-1602. PubMed ID: 36029073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges.
    Gaule TG; Ajjan RA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin drives thromboinflammation and neuropathology in COVID-19.
    Ryu JK; Yan Z; Montano M; Sozmen EG; Dixit K; Suryawanshi RK; Matsui Y; Helmy E; Kaushal P; Makanani SK; Deerinck TJ; Meyer-Franke A; Rios Coronado PE; Trevino TN; Shin MG; Tognatta R; Liu Y; Schuck R; Le L; Miyajima H; Mendiola AS; Arun N; Guo B; Taha TY; Agrawal A; MacDonald E; Aries O; Yan A; Weaver O; Petersen MA; Meza Acevedo R; Alzamora MDPS; Thomas R; Traglia M; Kouznetsova VL; Tsigelny IF; Pico AR; Red-Horse K; Ellisman MH; Krogan NJ; Bouhaddou M; Ott M; Greene WC; Akassoglou K
    Nature; 2024 Sep; 633(8031):905-913. PubMed ID: 39198643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases.
    Arouche TDS; Martins AY; Ramalho TC; Júnior RNC; Costa FLP; Filho TSA; Neto AMJC
    J Nanosci Nanotechnol; 2021 Apr; 21(4):2075-2089. PubMed ID: 33500022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2.
    Lehrer S; Rheinstein PH
    In Vivo; 2020; 34(5):3023-3026. PubMed ID: 32871846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
    Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.
    Hugenholtz GC; Macrae F; Adelmeijer J; Dulfer S; Porte RJ; Lisman T; Ariëns RA
    J Thromb Haemost; 2016 May; 14(5):1054-66. PubMed ID: 26833718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.
    Piechocka IK; Kurniawan NA; Grimbergen J; Koopman J; Koenderink GH
    J Thromb Haemost; 2017 May; 15(5):938-949. PubMed ID: 28166607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.